EA201690869A1 - СТАБИЛЬНЫЙ ПОЛИМОРФ СОЛИ (2R)-4-ОКСО-4-[3-(ТРИФТОРМЕТИЛ)-5,6-ДИГИДРО[1,2,4]ТРИАЗОЛО[4,3-α]ПИРАЗИН-7(8H)-ИЛ]-1-(2,4,5-ТРИФТОРФЕНИЛ)БУТАН-2-АМИНА И L-ВИННОЙ КИСЛОТЫ - Google Patents
СТАБИЛЬНЫЙ ПОЛИМОРФ СОЛИ (2R)-4-ОКСО-4-[3-(ТРИФТОРМЕТИЛ)-5,6-ДИГИДРО[1,2,4]ТРИАЗОЛО[4,3-α]ПИРАЗИН-7(8H)-ИЛ]-1-(2,4,5-ТРИФТОРФЕНИЛ)БУТАН-2-АМИНА И L-ВИННОЙ КИСЛОТЫInfo
- Publication number
- EA201690869A1 EA201690869A1 EA201690869A EA201690869A EA201690869A1 EA 201690869 A1 EA201690869 A1 EA 201690869A1 EA 201690869 A EA201690869 A EA 201690869A EA 201690869 A EA201690869 A EA 201690869A EA 201690869 A1 EA201690869 A1 EA 201690869A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- salt
- pyrazin
- triazolo
- butan
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Стабильный полиморф (форма Z1) соли (2R)-4-оксо-4-[3-(трифторметил)-5,6-дигидро[1,2,4]триазоло[4,3-α]пиразин-7(8Н)-ил]-1-(2,4,5-трифторфенил)бутан-2-амина (ситаглиптин) и L-винной кислоты формулы 1, который представляет собой очень подходящую форму активного фармацевтического ингредиента лекарственных средств, главным образом предназначенных для лечения диабета 2 типа. Способ получения стабильного полиморфа (форма Z1) соли ситаглиптина и L-винной кислоты, а также его применение для получения фармацевтической композиции.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2013-842A CZ2013842A3 (cs) | 2013-11-01 | 2013-11-01 | Stabilní polymorf soli (2R)-4-oxo-4-[3-(trifluorometyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorofenyl)butan-2-aminu s kyselinou L-vinnou |
PCT/CZ2014/000125 WO2015062562A1 (en) | 2013-11-01 | 2014-10-30 | A stable polymorph of the salt of (2r)-4-oxo-4-[3-(trifiuoromethyl)-5,6- dihydro[l,2,4]triazolo[4,3-a]pyrazin-7(8h)-yl]-l-(2,4,54rifluorophenyl)butan-2-amine with l-tartaric acid |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201690869A1 true EA201690869A1 (ru) | 2016-08-31 |
EA030029B1 EA030029B1 (ru) | 2018-06-29 |
Family
ID=52130030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201690869A EA030029B1 (ru) | 2013-11-01 | 2014-10-30 | СТАБИЛЬНЫЙ ПОЛИМОРФ СОЛИ (2R)-4-ОКСО-4-[3-(ТРИФТОРМЕТИЛ)-5,6-ДИГИДРО[1,2,4]ТРИАЗОЛО[4,3-α]ПИРАЗИН-7(8H)-ИЛ]-1-(2,4,5-ТРИФТОРФЕНИЛ)БУТАН-2-АМИНА И L-ВИННОЙ КИСЛОТЫ |
Country Status (17)
Country | Link |
---|---|
US (1) | US9862723B2 (ru) |
EP (1) | EP3063151B1 (ru) |
JP (1) | JP2016535045A (ru) |
KR (1) | KR20160078359A (ru) |
CN (1) | CN105705505A (ru) |
CZ (1) | CZ2013842A3 (ru) |
EA (1) | EA030029B1 (ru) |
ES (1) | ES2694350T3 (ru) |
IL (1) | IL245263A0 (ru) |
LT (1) | LT3063151T (ru) |
MX (1) | MX2016005173A (ru) |
PL (1) | PL3063151T3 (ru) |
PT (1) | PT3063151T (ru) |
TR (1) | TR201815737T4 (ru) |
UA (1) | UA119655C2 (ru) |
WO (1) | WO2015062562A1 (ru) |
ZA (1) | ZA201602731B (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ27898U1 (cs) * | 2015-01-13 | 2015-03-02 | Zentiva, K.S. | Krystalická modifikace 2 L-vínanu (3R)-3-amino-1-[3-(trifluormethyl)-6,8-dihydro-5H-[1,2,4,]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorfenyl)butan-1-onu |
CZ27930U1 (cs) * | 2015-01-13 | 2015-03-10 | Zentiva, K.S. | Krystalická modifikace 3 L-vínanu (3R)-3-amino-1-[3-(trifluormethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorfenyl)butan-1-onu |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
JO2625B1 (en) | 2003-06-24 | 2011-11-01 | ميرك شارب اند دوم كوربوريشن | Phosphoric acid salts of dipeptidyl betidase inhibitor 4 |
WO2005072530A1 (en) | 2004-01-16 | 2005-08-11 | Merck & Co., Inc. | Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor |
US20090221592A1 (en) * | 2005-07-25 | 2009-09-03 | Ellison Martha E | Dodecylsulfate Salt Of A Dipeptidyl Peptidase-Iv Inhibitor |
CN101903390A (zh) * | 2007-12-20 | 2010-12-01 | 雷迪博士实验室有限公司 | 制备西他列汀及其药学上可接受的盐的方法 |
-
2013
- 2013-11-01 CZ CZ2013-842A patent/CZ2013842A3/cs unknown
-
2014
- 2014-10-30 WO PCT/CZ2014/000125 patent/WO2015062562A1/en active Application Filing
- 2014-10-30 LT LTEP14815215.0T patent/LT3063151T/lt unknown
- 2014-10-30 PL PL14815215T patent/PL3063151T3/pl unknown
- 2014-10-30 MX MX2016005173A patent/MX2016005173A/es unknown
- 2014-10-30 ES ES14815215.0T patent/ES2694350T3/es active Active
- 2014-10-30 PT PT14815215T patent/PT3063151T/pt unknown
- 2014-10-30 KR KR1020167011175A patent/KR20160078359A/ko not_active Application Discontinuation
- 2014-10-30 TR TR2018/15737T patent/TR201815737T4/tr unknown
- 2014-10-30 EA EA201690869A patent/EA030029B1/ru not_active IP Right Cessation
- 2014-10-30 UA UAA201605947A patent/UA119655C2/uk unknown
- 2014-10-30 JP JP2016527233A patent/JP2016535045A/ja active Pending
- 2014-10-30 US US15/030,879 patent/US9862723B2/en active Active
- 2014-10-30 EP EP14815215.0A patent/EP3063151B1/en active Active
- 2014-10-30 CN CN201480059174.3A patent/CN105705505A/zh active Pending
-
2016
- 2016-04-20 ZA ZA2016/02731A patent/ZA201602731B/en unknown
- 2016-04-21 IL IL245263A patent/IL245263A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20160251360A1 (en) | 2016-09-01 |
US9862723B2 (en) | 2018-01-09 |
LT3063151T (lt) | 2018-12-10 |
CZ2013842A3 (cs) | 2015-05-13 |
EA030029B1 (ru) | 2018-06-29 |
UA119655C2 (uk) | 2019-07-25 |
CN105705505A (zh) | 2016-06-22 |
EP3063151B1 (en) | 2018-08-29 |
KR20160078359A (ko) | 2016-07-04 |
MX2016005173A (es) | 2016-07-08 |
WO2015062562A1 (en) | 2015-05-07 |
ZA201602731B (en) | 2017-07-26 |
IL245263A0 (en) | 2016-06-30 |
ES2694350T3 (es) | 2018-12-20 |
JP2016535045A (ja) | 2016-11-10 |
TR201815737T4 (tr) | 2018-11-21 |
PL3063151T3 (pl) | 2019-05-31 |
EP3063151A1 (en) | 2016-09-07 |
PT3063151T (pt) | 2018-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020011079A (es) | Forma cristalina de sulfato acido de (s)-n-(5-((r)-2-(2,5-difluoro fenil)-pirrolidin-1-il)-pirazolo[1,5-a]-pirimidin-3-il)-3-hidroxi pirrolidina-1-carboxamida. | |
NZ629511A (en) | Novel crystalline form of sitagliptin sulfate | |
WO2018033853A3 (en) | Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof | |
EA201300908A1 (ru) | ПРОИЗВОДНЫЕ 6-ЦИКЛОБУТИЛ-1,5-ДИГИДРОПИРАЗОЛО[3,4d]ПИРИМИДИН-4-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ PDE9A | |
EA201300620A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-b]ПИРИДАЗИНА И ИМИДАЗО[4,5-b]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ JAK | |
EA201170771A1 (ru) | Органические соединения | |
MY164274A (en) | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
CL2012003227A1 (es) | Compuestos macrociclicos que comprenden en el ciclo una porcion pirazolo[1,5-a]pirimidina, inhibidores de quinasa trk; composicion farmaceutica; proceso de preparación; y metodo para tratar un trastorno seleccionado de dolor, cancer, inflamacion, enfermedad neurodegenerativa o infeccion por trypanosoma cruzi. | |
EA201170962A1 (ru) | Препарат разагилина с отсроченным высвобождением действующего вещества | |
EA201201664A1 (ru) | Производные 6-циклоалкил-1,5-дигидропипазоло[3,4-d]пиримидин-4-она и их применение в качестве ингибиторов pde9a | |
DOP2010000263A (es) | Derivados de imidazo-[1,2-b]-piridazina para el tratamiento de enfermedad mediada por cinasa de tirosina c-met | |
WO2012034055A3 (en) | Compounds as c-met kinase inhibitors | |
PE20120534A1 (es) | PIRIMIDINAS FUSIONADAS COMO INHIBIDORES DE Akt | |
RU2015148189A (ru) | ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1 | |
EA201591804A1 (ru) | Производные 2-((4-амино-3-(3-фтор-5-гидроксифенил)-1h-пиразоло[3,4-d]пиримидин-1-ил)метил)-3-(2-(трифторметил)бензил)хиназолин-4(3h)-она и их применение в качестве ингибиторов фосфоинозитид-3-киназы | |
HRP20190814T1 (hr) | 7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-heksahidroimidazo[1,2-a]pirido[3,4-e]pirimidin-5(1h)-on, njegove soli i postupci uporabe | |
MX339302B (es) | 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina. | |
EA201690183A1 (ru) | Замещенные пиразолопиридинамины | |
RU2015102772A (ru) | Бензодиазелипы для мелкоклеточного рака легкого | |
GEP20196969B (en) | New therapeutical composition containing apomorphine as active ingredient | |
PE20171104A1 (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
AR084832A1 (es) | Derivado cristalino de oxazina | |
AR079136A1 (es) | Formas polimorfas de (4,6-diamino-2-(1-(2-fluorobencil)-1h- pirazolo (3,4-b) piridin -3-il)piridin -5-il) carbamato de metilo | |
EA201490045A1 (ru) | Дейтерированные 1-пиперазино-3-фенилинданы, применяемые для лечения шизофрении | |
EA201071352A1 (ru) | Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KZ RU |